S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS
Main Authors: | Olivier Demaria, Guillaume Habif, Francois Le Floch, Marianna Muller, Laura Chiossone, Romain Remark, Marie Vetizou, Nadia Maurel, Ariane Morel, Laurent Gauthier, Yannis Morel, Carine Paturel, Eric Vivier |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000967944.12345.32 |
Similar Items
-
Morphological Evolution of the Binahaan River, Palo, Leyte, 6501, Philippines
by: Kimberly Naputo, et al.
Published: (2023-07-01) -
Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients
by: Alessandra Vergori, et al.
Published: (2021-01-01) -
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control [version 2; peer review: 2 approved]
by: Mathieu Bléry, et al.
Published: (2021-10-01) -
258 Enhancing tumor infiltration of CAR T cells in solid tumors
by: Ananda Goldrath, et al.
Published: (2023-11-01) -
Análisis hidrológico de la Cuenca del Río Monday mediante el uso del modelo hidrológico distribuido MGB – IPH.
by: Teresita Godoy, et al.
Published: (2016-05-01)